Skip to main content

MoneyWorks4Me

Unichem Laboratories informs about press release

16 Mar 2022 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed a press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem’s Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1779.20
Dr. Reddys Labs. 1357.10
Cipla 1388.10
Lupin 2012.70
Zydus Lifesciences 1236.10
View more..